Inhibikase Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
Inhibikase Therapeutics, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 4 trademarks are registered and 2 are pending. Notable registered marks include IKT, RAMP, and INHIBIKASE. The owner is based in Atlanta, GA.
3350 Riverwood Parkway SE
Suite 1900
Atlanta, GA 30339
Showing of trademarks Trademarks
Trademark Classifications
Inhibikase Therapeutics, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Inhibikase Therapeutics, Inc. have?
Inhibikase Therapeutics, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 pending.
What trademark classes does Inhibikase Therapeutics, Inc. file in?
Inhibikase Therapeutics, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Inhibikase Therapeutics, Inc.'s most well-known trademarks?
Inhibikase Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as IKT, RAMP, and INHIBIKASE. These are among 4 currently registered trademarks in the portfolio.
What is Inhibikase Therapeutics, Inc.'s trademark registration success rate?
Inhibikase Therapeutics, Inc. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 2 applications are pending review.